265 related articles for article (PubMed ID: 25537177)
1. Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.
Raff U; Walker S; Ott C; Schneider MP; Schmieder RE
J Clin Hypertens (Greenwich); 2015 Feb; 17(2):98-104. PubMed ID: 25537177
[TBL] [Abstract][Full Text] [Related]
2. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
3. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen.
Hayoz D; Zappe DH; Meyer MA; Baek I; Kandra A; Joly MP; Mazzolai L; Haesler E; Periard D
J Clin Hypertens (Greenwich); 2012 Nov; 14(11):773-8. PubMed ID: 23126349
[TBL] [Abstract][Full Text] [Related]
4. The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension.
Ruilope L; Schaefer A
Adv Ther; 2013 Dec; 30(12):1086-99. PubMed ID: 24293132
[TBL] [Abstract][Full Text] [Related]
5. Effective systolic blood pressure reduction with olmesartan medoxomil/amlodipine combination therapy: post hoc analysis of data from a randomized, double-blind, parallel-group, multicentre study.
Mourad JJ; Le Jeune S
Clin Drug Investig; 2009; 29(6):419-25. PubMed ID: 19432501
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
Punzi H; Neutel JM; Kereiakes DJ; Shojaee A; Waverczak WF; Dubiel R; Maa JF
Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):209-21. PubMed ID: 20519261
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
Volpe M; Christian Rump L; Ammentorp B; Laeis P
Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
[TBL] [Abstract][Full Text] [Related]
8. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
London G; Schmieder R; Calvo C; Asmar R
Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
[TBL] [Abstract][Full Text] [Related]
9. Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes.
Redon J; Pichler G;
Am J Hypertens; 2016 Sep; 29(9):1055-62. PubMed ID: 27220840
[TBL] [Abstract][Full Text] [Related]
10. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients.
Matsui Y; Eguchi K; O'Rourke MF; Ishikawa J; Miyashita H; Shimada K; Kario K
Hypertension; 2009 Oct; 54(4):716-23. PubMed ID: 19667251
[TBL] [Abstract][Full Text] [Related]
11. Daytime systolic ambulatory blood pressure with a direct switch between candesartan monotherapy and the fixed-dose combination olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-1).
Zemmrich C; Lüders S; Gansz A; Sturm CD; Fimmers R; Nadal J; Schmieder RE; Schrader J; Bramlage P
J Clin Hypertens (Greenwich); 2013 Nov; 15(11):815-9. PubMed ID: 24102831
[TBL] [Abstract][Full Text] [Related]
12. A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.
Weir MR; Hsueh WA; Nesbitt SD; Littlejohn TJ; Graff A; Shojaee A; Waverczak WF; Qian C; Jones CJ; Neutel JM
J Clin Hypertens (Greenwich); 2011 Jun; 13(6):404-12. PubMed ID: 21649839
[TBL] [Abstract][Full Text] [Related]
13. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.
Litvin AY; Sukmarova ZN; Elfimova EM; Aksenova AV; Galitsin PV; Rogoza AN; Chazova IE
Vasc Health Risk Manag; 2013; 9():229-35. PubMed ID: 23690688
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan/amlodipine: a review of its use in the management of hypertension.
Kreutz R
Vasc Health Risk Manag; 2011; 7():183-92. PubMed ID: 21490944
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials.
de la Sierra A; Barrios V
Adv Ther; 2012 May; 29(5):401-15. PubMed ID: 22610686
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.
Chrysant SG; Oparil S; Melino M; Karki S; Lee J; Heyrman R
J Clin Hypertens (Greenwich); 2009 Sep; 11(9):475-82. PubMed ID: 19751459
[TBL] [Abstract][Full Text] [Related]
17. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
Chrysant SG; Melino M; Karki S; Lee J; Heyrman R
Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
Nesbitt SD; Shojaee A; Maa JF; Weir MR
J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
[TBL] [Abstract][Full Text] [Related]
20. The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure.
Bakris GL; Sica D; Weber M; White WB; Roberts A; Perez A; Cao C; Kupfer S
J Clin Hypertens (Greenwich); 2011 Feb; 13(2):81-8. PubMed ID: 21272195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
